• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种抑制胃酸的药理学方法。

A pharmacological approach to gastric acid inhibition.

作者信息

Esplugues Juan V

机构信息

Department of Pharmacology, Faculty of Medicine, University of Valencia, Spain.

出版信息

Drugs. 2005;65 Suppl 1:7-12. doi: 10.2165/00003495-200565001-00003.

DOI:10.2165/00003495-200565001-00003
PMID:16335853
Abstract

Proton pump inhibitors have changed our approach to gastric acid-related diseases. They are much more potent acid inhibitors than H2-antagonists and exhibit a sophisticated mechanism of action. The present review analyses the general pharmacology of proton pump inhibitors and differentiates the specific characteristics of the various compounds that belong to this family. Special emphasis has been placed in describing the clinical implications of such differences and the potential importance for adverse effects.

摘要

质子泵抑制剂改变了我们治疗胃酸相关疾病的方法。它们是比H2拮抗剂更强效的胃酸抑制剂,并且具有复杂的作用机制。本综述分析了质子泵抑制剂的一般药理学,并区分了该家族中各种化合物的具体特征。特别强调描述了这些差异的临床意义以及对不良反应的潜在重要性。

相似文献

1
A pharmacological approach to gastric acid inhibition.一种抑制胃酸的药理学方法。
Drugs. 2005;65 Suppl 1:7-12. doi: 10.2165/00003495-200565001-00003.
2
Optimising acid inhibition treatment.优化抑酸治疗
Drugs. 2005;65 Suppl 1:25-33. doi: 10.2165/00003495-200565001-00005.
3
Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.执业医师使用H2受体拮抗剂和质子泵抑制剂的药理学及药效学要点
Best Pract Res Clin Gastroenterol. 2001 Jun;15(3):355-70. doi: 10.1053/bega.2001.0184.
4
Pharmacologic properties of proton pump inhibitors.质子泵抑制剂的药理特性。
Pharmacotherapy. 2003 Oct;23(10 Pt 2):74S-80S. doi: 10.1592/phco.23.13.74s.31929.
5
Review article: the clinical pharmacology of proton pump inhibitors.综述文章:质子泵抑制剂的临床药理学
Aliment Pharmacol Ther. 2006 Jun;23 Suppl 2:2-8. doi: 10.1111/j.1365-2036.2006.02943.x.
6
What is potent acid inhibition, and how can it be achieved?什么是强效酸抑制,如何实现强效酸抑制?
Drugs. 2005;65 Suppl 1:13-23. doi: 10.2165/00003495-200565001-00004.
7
Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.基层医疗中质子泵抑制剂治疗酸相关性疾病的优化应用
Acta Gastroenterol Belg. 2013 Dec;76(4):393-402.
8
Safety of potent gastric acid inhibition.强效胃酸抑制的安全性。
Drugs. 2005;65 Suppl 1:97-104. doi: 10.2165/00003495-200565001-00013.
9
Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
Ital J Gastroenterol. 1990;22 Suppl 1:2-4.
10
The use of neem for controlling gastric hyperacidity and ulcer.印楝用于控制胃酸过多和溃疡。
Phytother Res. 2009 Jun;23(6):747-55. doi: 10.1002/ptr.2721.

引用本文的文献

1
Gastroprotective activity of ()-ethyl-12-cyclohexyl-4,5-dihydroxydodec-2-enoate, a compound isolated from : role of nitric oxide, prostaglandins, and sulfhydryls in its mechanism of action.()-乙基-12-环己基-4,5-二羟基十二碳-2-烯酸酯的胃保护活性,一种从 中分离得到的化合物:其作用机制中一氧化氮、前列腺素和巯基的作用。
Pharm Biol. 2022 Dec;60(1):1207-1213. doi: 10.1080/13880209.2022.2087690.
2
Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.使用木糖醇-苹果酸片作为辅助治疗胃食管反流病患者的唾液刺激效果:初步发现。
Med Oral Patol Oral Cir Bucal. 2020 Nov 1;25(6):e818-e826. doi: 10.4317/medoral.23887.

本文引用的文献

1
Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.根除幽门螺杆菌后,奥美拉唑治疗会导致胃酸分泌长期增加。
Gastroenterology. 2004 Apr;126(4):980-8. doi: 10.1053/j.gastro.2004.01.004.
2
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.埃索美拉唑、兰索拉唑、奥美拉唑、泮托拉唑和雷贝拉唑对胃酸的控制:一项五交叉研究。
Am J Gastroenterol. 2003 Dec;98(12):2616-20. doi: 10.1111/j.1572-0241.2003.08783.x.
3
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.
质子泵抑制剂的临床药理学:执业医师需要了解的内容。
Drugs. 2003;63(24):2739-54. doi: 10.2165/00003495-200363240-00004.
4
Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.口服埃索美拉唑与静脉注射泮托拉唑:对健康受试者胃内pH值影响的比较。
Aliment Pharmacol Ther. 2003 Oct 1;18(7):705-11. doi: 10.1046/j.1365-2036.2003.01743.x.
5
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.美国食品药品监督管理局报告的在使用奥美拉唑、兰索拉唑和泮托拉唑治疗期间发生的不良事件及药物相互作用总结。
Aliment Pharmacol Ther. 2003 Apr;17(8):1015-9. doi: 10.1046/j.1365-2036.2003.01550.x.
6
Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.泮托拉唑:其药理特性及在酸相关性疾病管理中的治疗应用的最新进展。
Drugs. 2003;63(1):101-33. doi: 10.2165/00003495-200363010-00006.
7
Rabeprazole: an update of its use in acid-related disorders.雷贝拉唑:其在酸相关性疾病中应用的最新进展
Drugs. 2001;61(15):2327-56. doi: 10.2165/00003495-200161150-00016.
8
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.埃索美拉唑(奥美拉唑的S-异构体)的药代动力学和药效学
Aliment Pharmacol Ther. 2001 Oct;15(10):1563-9. doi: 10.1046/j.1365-2036.2001.01087.x.
9
Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.埃索美拉唑(奥美拉唑的S-异构体)的药物相互作用研究。
Clin Pharmacokinet. 2001;40(7):523-37. doi: 10.2165/00003088-200140070-00004.
10
Rabeprazole: a review of its use in acid-related gastrointestinal disorders.雷贝拉唑:其在酸相关性胃肠疾病中的应用综述
Drugs. 1999 Oct;58(4):725-42. doi: 10.2165/00003495-199958040-00014.